Samsara Bio Capital, LLC Nkarta, Inc. Transaction History
Samsara Bio Capital, LLC
- $233 Million
- Q2 2025
A detailed history of Samsara Bio Capital, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Samsara Bio Capital, LLC holds 3,768,035 shares of NKTX stock, worth $7.39 Million. This represents 2.69% of its overall portfolio holdings.
Number of Shares
3,768,035
Previous 3,768,035
-0.0%
Holding current value
$7.39 Million
Previous $6.93 Million
9.79%
% of portfolio
2.69%
Previous 3.2%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
111Shares Held
59MCall Options Held
0Put Options Held
67.1K-
Ra Capital Management, L.P. Boston, MA10.8MShares$21.2 Million0.39% of portfolio
-
Tang Capital Management LLC San Diego, CA7.06MShares$13.8 Million0.7% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$7.96 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.99 Million0.49% of portfolio
-
Sr One Capital Management, LP3.33MShares$6.53 Million1.98% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $95.4M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...